Genuine Monovalent Ligands of TrkA Nerve Growth Factor Receptors Reveal a Novel Pharmacological Mechanism of Action
Open Access
- 1 April 2000
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (14) , 9946-9956
- https://doi.org/10.1074/jbc.275.14.9946
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Inverse agonism: pharmacological curiosity or potential therapeutic strategy?Published by Elsevier ,2000
- Small molecule and protein-based neurotrophic ligands: agonists and antagonists as therapeutic agentsExpert Opinion on Therapeutic Patents, 1999
- Small molecule nerve growth factor analogs image receptors in vivoNature Biotechnology, 1996
- The neurotrophin receptor, gp75, forms a complex with the receptor tyrosine kinase TrkA.The Journal of cell biology, 1996
- Diffusion‐weighted imaging in tissues: Theoretical modelsNMR in Biomedicine, 1995
- Kynurenic Acid Derivatives Inhibit the Binding of Nerve Growth Factor (NGF) to the Low-Affinity p75 NGF ReceptorJournal of Medicinal Chemistry, 1995
- Small Peptide Mimics of Nerve Growth Factor Bind TrkA Receptors and Affect Biological ResponsesJournal of Biological Chemistry, 1995
- The low affinity NGF receptor, p75, can collaborate with each of the Trks to potentiate functional responses to the neurotrophinsNeuron, 1994
- Partial agonists, full agonists, antagonists: dilemmas of definitionTrends in Pharmacological Sciences, 1993
- The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth FactorScience, 1991